November 18, 2026
Health news, explained with evidence
LIVE
Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine

Study Finds Mildly Reduced Alpha-1 Antitrypsin Levels Lack Link to Emphysema or Airflow Limitation

🧠 AI Analysis 2 min read 👁 0

A large population-based study in Sweden indicates that mildly reduced serum alpha-1 antitrypsin levels are not independently associated with chronic airflow limitation or CT-defined emphysema.

Study Finds Mildly Reduced Alpha-1 Antitrypsin Levels Lack Link to Emphysema or Airflow Limitation🧠AI Analysis

Photo: Nature Health Sciences

Key points

  • Evaluated data from 24,931 participants aged 50–65 in the Swedish SCAPIS cohort.
  • Found no independent link between mildly reduced AAT levels and chronic airflow limitation or emphysema.
  • Mildly reduced AAT levels were associated with lower odds of certain respiratory symptoms.

Researchers in Sweden have published findings from a large population-based cohort examining whether mildly reduced serum alpha-1 antitrypsin (AAT) concentrations pose a risk for chronic pulmonary conditions. While severe deficiency in AAT is a known genetic risk factor for chronic obstructive pulmonary disease and emphysema, the clinical implications of mildly reduced levels have remained unclear. Investigators utilized data from the Swedish CArdioPulmonary bioImage Study (SCAPIS), evaluating participants aged 50 to 65 years to understand how such levels relate to respiratory health and smoking.

Out of 24,931 individuals examined, 23,072 exhibited normal serum AAT concentrations, while 1,859 presented with mildly reduced levels. The researchers found no significant association between these mildly reduced concentrations and chronic airflow limitation, whether defined by standard GOLD criteria or the lower limit of normal, nor with emphysema detected via computed tomography scans. Interestingly, mildly reduced AAT levels even showed lower odds of certain reduced lung diffusion capacities and fewer respiratory symptoms compared to normal levels.

What to know: The authors suggest that mildly reduced AAT levels alone may not represent a major independent risk factor for airflow limitation or emphysema within the general population. Because this was an observational, cross-sectional evaluation relying on a specific age bracket, it has inherent design limits. Readers should consult a qualified healthcare provider for guidance regarding personal medical decisions and lung health assessments.

Source Nature Health Sciences — nature.com/articles/s41598-026-79511-0 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.